Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.39B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$790M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$648M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$411M |
| 5 |
Microsoft
MSFT
|
+$379M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$344M |
| 2 |
Consolidated Edison
ED
|
+$155M |
| 3 |
iShares MSCI United Kingdom ETF
EWU
|
+$154M |
| 4 |
Vanguard Total World Stock ETF
VT
|
+$146M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.52% |
| 2 | Financials | 5.73% |
| 3 | Healthcare | 5.63% |
| 4 | Communication Services | 4.65% |
| 5 | Consumer Discretionary | 4.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
Laureate Education
LAUR
$5.28B
| $1.58M | ﹤0.01% |
100,347
+28,697
| +40% | +$457K |
|
3152
PUT
Ionis Pharmaceuticals
IONS
$9.4B
| $1.57M | ﹤0.01% |
24,500
-42,000
| -63% | -$2.97M |
|
3153
Shenandoah Telecom
SHEN
$746M
| $1.57M | ﹤0.01% |
40,883
+25,256
| +162% | +$1.05M |
|
3154
OFG Bancorp
OFG
$2.21B
| $1.57M | ﹤0.01% |
66,128
-45,809
| -41% | -$912K |
|
|
SIVB
3155
CALL
DELISTED
SVB Financial Group
SIVB
| $1.57M | ﹤0.01% |
7,000
-2,300
| -25% | -$532K |
|
3156
AZZ Inc
AZZ
$4.54B
| $1.57M | ﹤0.01% |
34,031
+11,727
| +53% | +$525K |
|
3157
PUT
Targa Resources
TRGP
$55.1B
| $1.56M | ﹤0.01% |
39,800
+15,900
| +67% | +$631K |
|
|
PTLA
3158
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $1.56M | ﹤0.01% |
57,597
+34,197
| +146% | +$1.07M |
|
3159
Liberty Latin America Class C
LILAK
$1.64B
| $1.56M | ﹤0.01% |
106,202
+58,663
| +123% | +$958K |
|
|
TWOU
3160
DELISTED
2U Inc
TWOU
| $1.56M | ﹤0.01% |
1,383
+1,154
| +504% | +$1.7M |
|
3161
PUT
Signet Jewelers
SIG
$3.76B
| $1.56M | ﹤0.01% |
87,300
+17,300
| +25% | +$372K |
|
3162
PUT
AGNC Investment
AGNC
$12.9B
| $1.56M | ﹤0.01% |
92,600
+40,800
| +79% | +$709K |
|
3163
CALL
Fidelity National Information Services
FIS
$22.1B
| $1.56M | ﹤0.01% |
12,700
-58,900
| -82% | -$6.92M |
|
3164
Fate Therapeutics
FATE
$326M
| $1.55M | ﹤0.01% |
76,512
+43,706
| +133% | +$788K |
|
|
LMNX
3165
DELISTED
Luminex Corp
LMNX
| $1.55M | ﹤0.01% |
75,177
-44,247
| -37% | -$972K |
|
3166
PUT
Yum China
YUMC
$16.3B
| $1.55M | ﹤0.01% |
33,500
-12,100
| -27% | -$525K |
|
|
GRAF.U
3167
DELISTED
Graf Industrial Corp. Units, each consisting of One share of Common Stock and One redeemable Warrant
GRAF.U
| $1.54M | ﹤0.01% |
150,000
| – | – |
|
3168
Monolithic Power Systems
MPWR
$68.9B
| $1.54M | ﹤0.01% |
11,339
-11,175
| -50% | -$1.52M |
|
3169
PUT
CF Industries
CF
$17.3B
| $1.54M | ﹤0.01% |
33,000
-1,000
| -3% | -$43.4K |
|
3170
PUT
AGCO
AGCO
$7.2B
| $1.54M | ﹤0.01% |
19,800
+400
| +2% | +$28.5K |
|
|
AXDX
3171
DELISTED
Accelerate Diagnostics
AXDX
| $1.54M | ﹤0.01% |
6,713
+946
| +16% | +$185K |
|
|
KRA
3172
DELISTED
Kraton Corporation
KRA
| $1.54M | ﹤0.01% |
49,452
+28,518
| +136% | +$862K |
|
|
WRK
3173
PUT
DELISTED
WestRock Company
WRK
| $1.53M | ﹤0.01% |
42,100
+34,500
| +454% | +$1.27M |
|
3174
CALL
Pan American Silver
PAAS
$21.6B
| $1.53M | ﹤0.01% |
118,400
-91,378
| -44% | -$1.1M |
|
|
BHVN
3175
PUT
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $1.53M | ﹤0.01% |
+35,000
| New | +$1.97M |
|
Similar funds
Barclays's Q2 2019 Portfolio in Review
As of Q2 2019, Barclays held 7,617 positions worth $163B, up 13% from $145B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays deployed $14.2B of net new capital in Q2 2019, opening 457 new positions and adding to 3,922 existing holdings. Its largest new stake was Dow Inc: 2,580,874 shares worth $127M.
By sector, the portfolio is most concentrated in Technology at 8.5% of assets, up from 7.9% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street Communication Services Select Sector SPDR ETF, an estimated $344M trimmed.
- Barclays's largest Q2 2019 buy was Dow Inc: 2,580,874 shares worth $127M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q2 2019, an estimated $1.39B increase.
- Barclays's biggest Q2 2019 reduction was State Street Communication Services Select Sector SPDR ETF, cutting an estimated $344M.
- Barclays fully exited Bemis in Q2 2019, selling an estimated $33.4M.
- Barclays's ten largest holdings make up 25% of its $163B portfolio in Q2 2019.
- Barclays opened 457 new positions and closed 572 in Q2 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2019, filed 14 Aug 2019.